Octopus hitches ride on shark's back in remarkable footage that is ‘a reminder of the wonders of the ocean': ‘Sharktopus'
Forget 'sharknado' — this footage shows a new feat of nature.
Researchers from the University of Aukland got a chance sighting of an octopus hitching a ride on the back of a shark, which they have dubbed 'sharktopus.'
The team was off the Northern coast of New Zealand in the Hauraki Gulf in 2023 when they spotted a shortfin mako shark with an orange blob attached to its back.
Upon closer inspection, they realized it was a Maori octopus when they spotted its tentacles moving.
'At first, I was like: 'Is it a buoy?'' marine scientist Rochelle Constantine told the New York Times. ''Is it entangled in fishing gear or had a big bite?''
The phenomenon was particularly remarkable because of the nature of both creatures. Octopuses usually are on the ocean floor, where shortfin mako sharks typically do not go.
'It makes no sense that these two animals should be at the same place and time to encounter each other,' Constantine said, adding that both marine animals seemed 'quite happy.'
'We have no idea how they found each other.'
While the researchers only stayed to watch the aquatic animals for 10 minutes, Constantine mused that the octopus was in for the ride of its life.
'The octopus may have been in for quite the experience, though, since the world's fastest shark species can reach 50 kilometers per hour,' she told Oceanographic.
But, according to the outlet, octopuses can travel at a maximum of 40 kilometers, or 25 miles, per hour.
'The 'sharktopus' encounter is a reminder of the wonders of the ocean,' Constantine continued.
'One of the best things about being a marine scientist is that you never know what you might see next in the sea. By supporting conservation initiatives, we can help to ensure that such extraordinary moments keep happening.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
4 days ago
- Los Angeles Times
Want to feel 50 at 80? ‘Super Agers' researcher shares his do's and don'ts
Cardiologist Eric Topol is one of the leading medical researchers in the world. A founder of the Scripps Research Translational Institute in La Jolla, Calif., Dr. Topol is also the author of a New York Times bestselling new book, 'Super Agers: An Evidence Based Approach to Longevity.' I recently sat down with Topol to discuss his book's insights into slowing down, or turning back, our aging clocks to become more like super agers — or who he calls the 'Wellderly' — people who live well into their 80s and 90s without any chronic illness or disease. A comprehensive answer to that question requires reading his book, written for a lay audience curious about the latest (and upcoming) scientific breakthroughs in longevity medicine. But in our hour-long conversation, Topol discussed several do's and don'ts for anyone seeking to make 80 the new 50. If there is one main thesis to Topol's book, it's that healthy aging is a function of a strong immune system, which can defend against diabetes, cancer, heart disease and other chronic conditions. 'I keep saying to myself that old thing about the economy: 'It's the immune system, stupid,' you know?' Topol told me. 'Because it really is.' He suggests focusing on habits that support and build immune health: I'll go deeper into some of these specific strategies, like sleep and nutrition, below. But the common denominator is supporting a robust immune function, Topol said. 'We should be having immune system testing as we get older,' he said, 'because it is the reason why aging can hurt us.' Most employer-provided health insurance programs cover only the minimum annual tests to gauge basic heart health and disease risks, cholesterol level and hormone health. 'Standard medicine is missing out, leaving too many unsolved questions about a person's risk,' Topol said. 'Just do the tests based on a person's risk; the yield is much higher.' He recommends a few lower-cost, specific tests to help personalize medical care and guide preventive strategies that can help flag potential disease risks that most insurance-covered tests do not: In 'Super Agers,' Topol writes at length about the bidirectional communication between gut hormones and the brain, and calls it critical to healthy immune function. Gut hormones are chemical messengers made by special cells in the digestive tract that help control digestive functions. They communicate with the brain through the bloodstream and the vagus nerve, which runs through the throat and vocal cords and connects the gut and brain. 'I'm pretty well-convinced now that the gut hormone story is the most extraordinary thing I've ever seen in medical intervention,' he told me. 'Because the gut hormones talk to the immune system, and they talk to the brain, which is mission control for the immune system.' 'It isn't just the microbiome, it's the gut's hormone production,' he said. 'The way to a person's brain and to healthy aging, it likely will be through their gut.' Here's how to nourish the two-way communication along the so-called gut-brain axis: We all know that getting enough sleep is critical to health and specifically to healthy aging, and many doctors rightfully call Americans' chronic lack of proper sleep a public health crisis. But there's another side to the sleep story, Topol said, admitting his own surprise: According to plenty of clinical research, for people in their late 30s and older, getting more than seven to eight hours of sleep was associated with greater mortality risks, he said. 'The principal finding was that about seven hours is the optimal duration of sleep,' he writes in his book. 'Every one-hour-a-night increase in sleep duration above that seven- to eight-hour threshold is associated with 12% higher risk of total cardiovascular disease.' To improve sleep function, Topol recommends maintaining a consistent bedtime and waking schedule, and avoiding eating or drinking alcohol for a few hours before sleep. The convergence of AI with advances in biomedical data — such as genomics, microbiome analysis and digital health monitoring — create a transformative force that can radically improve disease prediction, prevention and personalized care, Topol told me. For consumers, AI is a powerful tool, he said, that can still be grossly mistaken, sometimes. So with caution and vigilance for AI 'hallucinations' that provide flat-out wrong information, here's how you can use it to help you age with strength:
Yahoo
5 days ago
- Yahoo
Brain Drain: Talented Young People Are Abandoning Plans to Become Scientists as White House Undermines the Entire Career
As the Trump administration continues its crusade against the institutions of science, the careers of would-be researchers in the US are on the line. President Donald Trump has suggested slashing NASA's science directorate's budget in half, which could deal a fatal blow to dozens of future science missions and greatly undermine the United States' leadership in space, experts warn. Trump's outright anti-science agenda could have devastating knock-on effects for anybody looking to make a career in the sciences, preventing the next generation of researchers from flourishing — and likely curtailing decades of cutting-edge research that long distinguished the US on the world stage. Researchers are already looking for greener pastures as job opportunities dry up in the US. The troubling trend is kickstarting a brain drain that could massively undercut the nation's supremacy in fields ranging from medicine to biology to physical sciences, as the New York Times reports. Meanwhile, the US has shut down its borders to some of the brightest minds, denying visas to Chinese students pursuing educations. With grant money drying up fast, researchers are moving abroad, enticed by the promise of building out a career in a politically more stable place. China and Europe, in particular, are looking to swipe up an immense amount of talent as the number of graduate student or postdoctoral positions in the US continue to crater. "We are embarking on a major experiment in restructuring the innovative engine in America, and China is the control," geophysicist and the president of the National Academy of Sciences, Marcia McNutt, told the NYT. "China is not going to cut its research budget in half." Trump's cabinet seems to have little fear of national brain drain or missing out on international science talent. As the NYT points out, at least half of the workers in the US with doctorates were born abroad. It all comes in the context of the White House's assault on the most influential academic institutions in the country. Trump has directly targeted international students, going as far as to attempt to prevent Harvard University from enrolling foreign-born students, a horrifying decision that was blocked by a judge last week. The executive branch also recently temporarily halted student visa appointments, triggering panic among students from around the world. In short, the Trump administration has made it very clear that the United States is a hostile place to build a career as a scientist, whether you were born within its borders or not. "What we see is a full-scale assault on science in America," representative George Whitesides (D-CA) told PBS. "It is probably the biggest attack on our scientific establishment in history." More on brain drain: Nobel-Winning Scientist Says His Researchers Are Fleeing the Country Because of Trump's Cruelty
Scientific American
29-05-2025
- Scientific American
These Climbers Summited Mount Everest in Record Time. Did Inhaling Xenon Help?
Last week a quartet of British climbers made it to the top of Mount Everest —and spent less than a week on the total round trip from London. That's weeks fewer than it usually takes to acclimate to the high elevation, scale the world's highest peak and head home. Their guide, speaking to the New York Times, credited their accomplishment to a secret advantage: prior to the trip, the climbers inhaled xenon gas, which may have made their acclimatization to the low-oxygen environment of Everest easier. But experts on the medical uses of xenon are uncertain that it was a decisive factor. 'Maybe there is something there. We just don't know,' says Andrew Subudhi, a professor of human physiology and nutrition at the University of Colorado Colorado Springs, who studies human performance in low-oxygen environments. 'From the scientific evidence, I can't see anything that is definitive or even proof-of-concept yet.' On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. How does xenon work in the body? Xenon is a noble gas—colorless, odorless, inert. But it does affect the body. It's been used as an anesthetic on occasion since the 1950s, says Robert Dickinson, a senior lecturer in medicine at Imperial College London. Dickinson has long studied another intriguing aspect of xenon: the gas has shown neuroprotective effects after a brain injury such as a stroke or a traumatic blow to the head. This protective quality has been demonstrated in many animal studies and a handful of small human trials, Dickinson says. Both the anesthetic and potential neuroprotective effects occur because xenon can bind to brain receptors called N-methyl-D-aspartate (NMDA) receptors. Activating these receptors has an excitatory effect on neurons, but xenon tamps down NMDA activity. After a brain injury, NMDA receptors can become overexcited, causing further cell death, so quieting these receptors might prevent additional damage. Those are xenon's best-studied effects on human health. But the gas has also piqued interest in the sports medicine world because it can increase the production of erythropoietin (EPO), a hormone that is known to stimulate the bone marrow to increase its production of red blood cells. Red blood cells carry oxygen, which is, of course, in short supply on the icy slopes of Mount Everest. Can xenon really acclimate someone to high elevations? Before attempting Everest's summit, climbers must hang out in Kathmandu, Nepal, and then Everest Base Camp for weeks, lest they fall prey to altitude sickness, which is marked by fatigue, headache, nausea and confusion. In serious cases, the lungs fill with fluid or the brain swells, which can quickly lead to death. The air at Everest Base Camp contains about half the oxygen as is present at sea level, and the air at the summit contains a mere 33 percent. Xenon's potential to increase the production of red blood cells, thus increasing the blood's ability carry oxygen, raises the question of whether it might provide a performance boost or prevent altitude sickness in the athletes climbing the world's highest peaks. The problem is: no one really knows if the EPO boost provided by xenon is enough to make a real difference in how someone handles a high elevation. Davide Cattano, an anesthesiologist at the McGovern Medical School at the University of Texas Health Science Center at Houston, did some of the animal research that has shown that xenon increases a blood factor called hypoxia-inducible factor 1–alpha (HIF-1α), which in turn can increase EPO. He's skeptical that the recent Everest climbers saw much benefit. 'The level of HIF that you're inducing does not justify this superhuman capability,' Cattano says. One 2019 study published in the Journal of Applied Physiology tested 12 runners who were randomly assigned to inhale air that contained 70 percent xenon or a sham gas for two minutes each day for several weeks before they ran three kilometers. The runners who inhaled xenon saw an increase in EPO in their blood, but they didn't show any improvement in fitness or athletic performance, as measured by their running speed and their heart rate and respiration during exercise. Even dosing people with EPO directly with injections may not prevent altitude sickness or improve performance at high elevation, Subudhi says. In a study that is currently in review for publication in a scientific journal, he and his colleagues tested EPO injections on a small group of mountain-climbing athletes, and these subjects didn't see any benefits. It's possible a different dose or a longer course of treatment might make a difference, Subudhi says, but 'my enthusiasm for chasing that is much less when I didn't see anybody have a measurable benefit.' Why did the recent Everest climbers reach the peak so quickly? It is possible xenon improved the climbers' oxygen-carrying capacity by boosting their EPO, experts say. It's also possible the anesthetic and analgesic effects of the gas ameliorated the climbers' aches and pains or the fatigue from altitude, Cattano speculates. Just the act of breathing a heavy gas like xenon might also result in some change to lung capacity, he says, even if the EPO effect is small. But the athletes also did something else: they slept in hypoxic tents for weeks before traveling to the mountain. These tents create a low-oxygen environment, which definitely increases EPO and red blood cell production. This preacclimatization, plus the climbers' intensive training regime, may have done the trick. Whether the xenon added any benefit on top of the hypoxic tents is unclear, Dickinson says. Xenon is expensive, which has limited its use as an anesthetic and in athletics. But more people will probably shell out for the gas, given that the baseline cost of climbing Mount Everest is so expensive and the stakes are so high, Subudhi says. 'People are literally fighting for their lives at high altitudes, and if you're doing things that may give you a small chance of improving your rate of success, yeah, it might be worth it to some people,' he says. 'Not everybody is going to sit there and make a completely scientific decision about their life.'
